Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)

TWD 36.4

(-0.41%)

Revenue Summary of Nang Kuang Pharmaceutical Co., Ltd.

  • Nang Kuang Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 2.15 Billion TWD , up 10.81% from previous year.
  • Nang Kuang Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 528.46 Million TWD , up 2.36% from previous quarter.
  • Nang Kuang Pharmaceutical Co., Ltd. reported a annual revenue of 1.94 Billion TWD in annual revenue 2022, up 9.01% from previous year.
  • Nang Kuang Pharmaceutical Co., Ltd. reported a annual revenue of 1.78 Billion TWD in annual revenue 2021, up 1.44% from previous year.
  • Nang Kuang Pharmaceutical Co., Ltd. reported a quarterly revenue of 512.29 Million TWD for 2024 Q2, down -3.06% from previous quarter.
  • Nang Kuang Pharmaceutical Co., Ltd. reported a quarterly revenue of 516.3 Million TWD for 2023 Q4, down -3.86% from previous quarter.

Annual Revenue Chart of Nang Kuang Pharmaceutical Co., Ltd. (2023 - 2009)

Historical Annual Revenue of Nang Kuang Pharmaceutical Co., Ltd. (2023 - 2009)

Year Revenue Revenue Growth
2023 2.15 Billion TWD 10.81%
2022 1.94 Billion TWD 9.01%
2021 1.78 Billion TWD 1.44%
2020 1.75 Billion TWD -0.42%
2019 1.76 Billion TWD 14.54%
2018 1.53 Billion TWD 2.31%
2017 1.5 Billion TWD -2.97%
2016 1.54 Billion TWD 1.93%
2015 1.52 Billion TWD 19.07%
2014 1.27 Billion TWD 26.05%
2013 1.01 Billion TWD 6.38%
2012 952.13 Million TWD 17.1%
2011 813.12 Million TWD 24.55%
2010 652.82 Million TWD -2.57%
2009 670.02 Million TWD 0.0%

Peer Revenue Comparison of Nang Kuang Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
Maxigen Biotech Inc. 622.11 Million TWD -245.632%
SciVision Biotech Inc. 712.98 Million TWD -201.58%
Bionime Corporation 1.75 Billion TWD -22.481%
Pegavision Corporation 6.78 Billion TWD 68.332%
Visco Vision Inc. 2.39 Billion TWD 10.32%